scholarly article | Q13442814 |
P356 | DOI | 10.1002/CNCR.22481 |
P698 | PubMed publication ID | 17238190 |
P50 | author | Hiroyuki Tsuchiya | Q87251357 |
P2093 | author name string | Takeshi Ishii | |
Akihiko Matsumine | |||
Satoshi Abe | |||
Toshifumi Ozaki | |||
Kazuhiro Tanaka | |||
Akira Kawai | |||
Japanese Musculoskeletal Oncology Group | |||
Takafumi Ueda | |||
Hideto Obata | |||
Hiroo Yabe | |||
P2860 | cites work | Nonparametric Estimation from Incomplete Observations | Q25938997 |
Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study) | Q28366229 | ||
Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital | Q33329815 | ||
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors | Q33496601 | ||
Survival after recurrence of Ewing's sarcoma family of tumors | Q36076700 | ||
Ethnic group and survival from childhood cancer: report from the UK Children's Cancer Study Group | Q36641643 | ||
Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy | Q39340821 | ||
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli | Q40628011 | ||
Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone | Q40727404 | ||
Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. | Q43543641 | ||
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. | Q43626751 | ||
Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials | Q44263749 | ||
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone | Q44320806 | ||
Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group | Q44557261 | ||
Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. | Q44583963 | ||
Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial | Q45230926 | ||
Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma | Q47256715 | ||
Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies | Q50886149 | ||
Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience | Q57012134 | ||
Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II | Q67244298 | ||
Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81 | Q68521637 | ||
Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma | Q70505771 | ||
International variations in the incidence of childhood bone tumours | Q70550118 | ||
Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group | Q72504188 | ||
Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities | Q72888572 | ||
Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities | Q73437697 | ||
Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG) | Q73446743 | ||
Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol | Q73721648 | ||
Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients | Q77302606 | ||
Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study | Q77562044 | ||
EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-- preliminary results | Q78205464 | ||
Hemiarthroplasty of the elbow with a vascularized fibular graft after excision of Ewing's sarcoma of the proximal ulna: a case report | Q78570760 | ||
P433 | issue | 4 | |
P921 | main subject | Japan | Q17 |
P304 | page(s) | 767-775 | |
P577 | publication date | 2007-02-01 | |
P1433 | published in | Cancer | Q326041 |
P1476 | title | Clinical outcome of patients with Ewing sarcoma family of tumors of bone in Japan: the Japanese Musculoskeletal Oncology Group cooperative study | |
P478 | volume | 109 |
Q46717423 | A new strategy to remove broken femoral mega-prostheses with hollow trephine reamers |
Q64251223 | A nomogram to predict prognosis in Ewing sarcoma of bone |
Q52685819 | Clinical outcomes of radio-hyperthermo-chemotherapy for soft tissue sarcoma compared to a soft tissue sarcoma registry in Japan: a retrospective matched-pair cohort study. |
Q41963515 | Clinicopathologic characteristics and outcome of childhood and adolescent Ewing's sarcoma in center of Iran. |
Q46693659 | Clinicopathological Features and Treatment Outcomes in Ewing's Sarcoma Patients: A 10-year experience of Alexandria Clinical Oncology Department |
Q36262280 | Current management of pediatric soft tissue sarcomas |
Q28085071 | Diagnosis and treatment of Ewing sarcoma of the bone: a review article |
Q43174383 | Ewing's sarcoma family of tumors of the maxillary sinus: a case report of multidisciplinary examination enabling prompt diagnosis |
Q91740929 | Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a case report and literature review |
Q48023123 | Extraskeletal Ewing's Sarcoma Family of Tumors in Adults: Prognostic Factors and Clinical Outcome |
Q36135781 | Gastric Ewing sarcoma/primitive neuroectodermal tumor: A case report |
Q58565355 | Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma |
Q37532315 | Impact of treatment protocol on outcome of localized Ewing's sarcoma |
Q46260307 | Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone |
Q28073218 | Management of Ewing sarcoma family of tumors: Current scenario and unmet need |
Q64926660 | Massive FungatingEwing's Sarcoma of Scapula Treated by Limb Salvage Surgery: A Case Report. |
Q86635580 | Multidisciplinary therapy including proton beam radiotherapy for a Ewing sarcoma family tumor of maxillary sinus in a 4‐year‐old girl |
Q42172703 | Outcome of multimodality treatment of Ewing's sarcoma of the extremities |
Q36988855 | Outcomes of 50 Patients With Ewing Sarcoma Family of Tumors Treated at a Single Institution in Taiwan |
Q46581978 | Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population |
Q43148676 | Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney that responded to low-dose chemotherapy with ifosfamide, etoposide, and doxorubicin |
Q83603523 | Prognostic significance of HLA class I expression in Ewing's sarcoma family of tumors |
Q88020702 | Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma |
Q38100720 | The Treatment Outcome for Adult Patients with Ewing’s Sarcoma |
Q37426036 | Validation of radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas: Japanese Orthopaedic Association Committee on Musculoskeletal Tumors Cooperative Study |
Search more.